Find a Tender · Tender
Transitional Drugs 7
A public procurement published by NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) via Find a Tender.
- —
- Award value
- £53.6m
- Tender value
- 0
- Suppliers
- 0
- Awards
- 2
- Notices
- Tender
- Stage
Overview
This is a contract for the provision of Drugs that have recently lost patent - Eculizumab, Tocilizumab, Nintedanib and Omalizumab
Key details
- Buyer
- NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Source
- Find a Tender
- Lifecycle stage
- Tender
- Status
- planning
- CPV classification
- —
- Currency
- GBP
- Total award value
- —
- Tender value
- £53,566,932
- First published
- 8 Apr 2026
- Last updated
- 10 Apr 2026
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
FAQs about this procurement
Who is the buyer for "Transitional Drugs 7"?
Transitional Drugs 7 is a UK public-sector procurement published by NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) via Find a Tender.
Has "Transitional Drugs 7" been awarded?
No award has been recorded yet. The current lifecycle stage is "Tender".
What is "Transitional Drugs 7" worth?
The reported tender value is £53,566,932.
When was "Transitional Drugs 7" published?
It was first published on 8 Apr 2026 and last updated on 10 Apr 2026, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable